CTKB
Cytek Biosciences, Inc.Company with tickers: CTKB
CIK
1831915
CUSIP
23285D109
Shares Outstanding
129,142,587
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $44,135,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | $21,254,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | $39,717,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $9,604,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-18,463,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-18,866,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |